Working… Menu
Trial record 2 of 2 for:    janssen prevalence | prostate cancer

CTC Immune Checkpoint

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02456571
Recruitment Status : Completed
First Posted : May 28, 2015
Last Update Posted : July 9, 2019
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Duke University

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 13, 2019
Actual Study Completion Date : June 13, 2019